PAVmed and Lucid Diagnostics to Provide Strategic Business Update

Author's Avatar
Jan 11, 2023

PAVmed+Inc. (Nasdaq: PAVM, PAVMZ), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned subsidiaries Lucid+Diagnostics+Inc. (Nasdaq: LUCD), a commercial-stage cancer prevention diagnostics company, and Veris+Health+Inc.%2C a digital health company focused on enhanced personalized cancer care, today announced they will hold a joint conference call to provide a strategic business update on Tuesday, January 17, 2023 at 4:30PM EDT.